Literature DB >> 16273395

Differential effects of subthalamic nucleus stimulation in advanced Parkinson disease on reaction time performance.

Yasin Temel1, Arjan Blokland, Linda Ackermans, Peter Boon, Vivianne H J M van Kranen-Mastenbroek, E A M Beuls, Geert H Spincemaille, Veerle Visser-Vandewalle.   

Abstract

The aim of the present study was to assess the effect of bilateral subthalamic nucleus (STN) stimulation and dopaminergic medication on speed of mental processing and motor function. Thirty-nine patients suffering from advanced Parkinson disease (PD) were operated on. Motor function and reaction time (RT) performance [simple RT (SRT) and complex RT (CRT)] were evaluated under four experimental conditions with stimulation (stim) and medication (med) on and off: stim-on/med-on, stim-on/med-off, stim-off/med-off and stim-off/med-on. In the last condition, the patients received either low medication (usual dose) or high medication (suprathreshold dose). STN stimulation improved the motor performance in the SRT and CRT tasks. Furthermore, STN deep brain stimulation (DBS) also improved response preparation as shown by the significant improvement of the RT performance in the SRT task. This effect of STN DBS on the RT performance in the SRT task was greater as compared with the CRT task. This is due to the more complex information processing that is required in the CRT task as compared to the SRT task. These data suggest that treatment of STN hyperactivity by DBS improves motor function, confirming earlier reports, but has a differential effect on cognitive functions. The STN seems to be an important modulator of cognitive processing and STN DBS can differentially affect motor and associative circuits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273395     DOI: 10.1007/s00221-005-0151-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  65 in total

1.  High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons.

Authors:  C Beurrier; B Bioulac; J Audin; C Hammond
Journal:  J Neurophysiol       Date:  2001-04       Impact factor: 2.714

2.  Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease.

Authors:  G Vingerhoets; C van der Linden; E Lannoo; V Vandewalle; J Caemaert; M Wolters; D Van den Abbeele
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

3.  Cognitive changes following subthalamic nucleus stimulation in two patients with Parkinson disease.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Livio Capus; Manuela Gioulis; Sandro Zambito Marsala; Giuseppe Cazzato; Antonio Bava
Journal:  Percept Mot Skills       Date:  2002-10

4.  Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

Authors:  B Pillon; C Ardouin; P Damier; P Krack; J L Houeto; H Klinger; A M Bonnet; P Pollak; A L Benabid; Y Agid
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

5.  High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.

Authors:  Yassine Darbaky; Claude Forni; Marianne Amalric; Christelle Baunez
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

6.  Deep brain stimulation creates an informational lesion of the stimulated nucleus.

Authors:  Warren M Grill; Andrea N Snyder; Svjetlana Miocinovic
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

7.  The impact of deep brain stimulation on executive function in Parkinson's disease.

Authors:  M Jahanshahi; C M Ardouin; R G Brown; J C Rothwell; J Obeso; A Albanese; M C Rodriguez-Oroz; E Moro; A L Benabid; P Pollak; P Limousin-Dowsey
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

8.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

9.  Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease.

Authors:  J A Cooper; H J Sagar; P Tidswell; N Jordan
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

Review 10.  Deep brain stimulation for Parkinson's disease: disrupting the disruption.

Authors:  Andres M Lozano; Jonathan Dostrovsky; Robert Chen; Peter Ashby
Journal:  Lancet Neurol       Date:  2002-08       Impact factor: 44.182

View more
  15 in total

1.  A case report on fixation instability in Parkinson's disease with bilateral deep brain stimulation implants.

Authors:  H A C Wark; P C Garell; A L Walker; M A Basso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04       Impact factor: 10.154

2.  Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

Authors:  Jay L Alberts; Claudia Voelcker-Rehage; Katie Hallahan; Megan Vitek; Rashi Bamzai; Jerrold L Vitek
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

3.  High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease.

Authors:  Erwin B Montgomery; He Huang; Harrison C Walker; Barton L Guthrie; Ray L Watts
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

4.  High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease.

Authors:  Xiang-Hong Li; Jin-Yan Wang; Ge Gao; Jing-Yu Chang; Donald J Woodward; Fei Luo
Journal:  J Neurosci Res       Date:  2010-05-15       Impact factor: 4.164

Review 5.  The role of the subthalamic nucleus in cognition.

Authors:  David B Weintraub; Kareem A Zaghloul
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

Review 6.  Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease.

Authors:  Sabato Santaniello; John T Gale; Sridevi V Sarma
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-20

7.  Effects of STN DBS on memory guided force control in Parkinson's disease (June 2007).

Authors:  Janey Prodoehl; Daniel M Corcos; John C Rothwell; Leo Verhagen Metman; Roy A E Bakay; David E Vaillancourt
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2007-06       Impact factor: 3.802

8.  Modulation of habit formation by levodopa in Parkinson's disease.

Authors:  Frank Marzinzik; Johann Wotka; Michael Wahl; Lea K Krugel; Catarina Kordsachia; Fabian Klostermann
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review.

Authors:  João Massano; Carolina Garrett
Journal:  Front Neurol       Date:  2012-04-26       Impact factor: 4.003

10.  Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.

Authors:  Hsiao-Yun Lin; Wei-Lan Yeh; Bor-Ren Huang; Chingju Lin; Chih-Ho Lai; Ho Lin; Dah-Yuu Lu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.